Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Articles by Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Latest Updated Articles
- Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple Myeloma
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine
2
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
3
3 New Study Findings to Look Out for at Menopause Society 2025
4
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
5
